Literature DB >> 18333275

Use of a collagen-sealing device in hepatic resection: a comparative analysis to standard resection technique.

T Cheang1, S S Hanna, F C Wright, C H L Law.   

Abstract

BACKGROUND: Blood transfusion has been reported as an independent risk factor for poor outcome after liver resection in spite of its well known benefits. Refinements in parenchymal dissection have been pursued to reduce blood loss and transfusion. A collagen-sealing device (CSD) has recently been touted as an alternative technique that aids in blood conservation. We report the results of our initial series of patients undergoing a CSD-assisted resection and present a historical comparison. PATIENTS AND METHODS: Consecutive patients who were undergoing liver resection at a single tertiary cancer centre were enrolled in this study. The Ligasure Atlas device (Valleylab Inc., Division of Tyco Healthcare) was used for parenchymal division in the CSD group. Known blood conservation techniques (i.e. low central venous pressure, ultrasonic dissection, Pringle clamp) were standardized in both groups. Clinical and outcome variables including operative time, estimated blood loss and transfusion requirements were collected. All statistical analyses were performed with SAS version 8.2e.
RESULTS: In all, 28 consecutive patients underwent CSD-assisted hepatic resection between October 2003 and September 2004. The control group included 188 patients treated between January 1991 and September 2003. In the CSD group, we observed a reduction in mean estimated blood loss (930 vs 1450 ml, p=0.002) and mean transfusion requirements (0.46 vs 1.19 units, p=0.002). There was no increase in operative time with the new instrument (326 vs 363 min, p=0.167). DISCUSSION: Use of a CSD has the potential to further reduce blood loss and transfusion requirements without increasing operative time.

Entities:  

Year:  2006        PMID: 18333275      PMCID: PMC2131684          DOI: 10.1080/13651820600593087

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  17 in total

1.  A novel technique for parenchymal division during hepatectomy.

Authors:  P G Horgan
Journal:  Am J Surg       Date:  2001-03       Impact factor: 2.565

2.  Randomised trial comparing LigaSure haemorrhoidectomy with the diathermy dissection operation.

Authors:  G Milito; M Gargiani; F Cortese
Journal:  Tech Coloproctol       Date:  2002-12       Impact factor: 3.781

3.  Use of a bipolar vessel-sealing device for parenchymal transection during liver surgery.

Authors:  Steven M Strasberg; Jeffrey A Drebin; David Linehan
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

4.  Laparoscopic splenectomy using Ligasure. Preliminary experience.

Authors:  F Romano; R Caprotti; C Franciosi; S De Fina; G Colombo; F Uggeri
Journal:  Surg Endosc       Date:  2002-05-03       Impact factor: 4.584

5.  Randomized clinical trial of Ligasure versus conventional diathermy for day-case haemorrhoidectomy.

Authors:  D G Jayne; I Botterill; N S Ambrose; T G Brennan; P J Guillou; D S O'Riordain
Journal:  Br J Surg       Date:  2002-04       Impact factor: 6.939

6.  LigaSure versus clamp-and-tie thyroidectomy for benign nodular disease.

Authors:  Ioannis E Petrakis; Nektarios E Kogerakis; Kostas G Lasithiotakis; Nikolaos Vrachassotakis; Georgios E Chalkiadakis
Journal:  Head Neck       Date:  2004-10       Impact factor: 3.147

7.  A comparison of laparoscopically assisted and open colectomy for colon cancer.

Authors:  Heidi Nelson; Daniel J Sargent; H Sam Wieand; James Fleshman; Mehran Anvari; Steven J Stryker; Robert W Beart; Michael Hellinger; Richard Flanagan; Walter Peters; David Ota
Journal:  N Engl J Med       Date:  2004-05-13       Impact factor: 91.245

8.  Bloodless liver resection using the monopolar floating ball plus ligasure diathermy: preliminary results of 16 liver resections.

Authors:  Yoshihiro Sakamoto; Junji Yamamoto; Norihiro Kokudo; Makoto Seki; Tomoo Kosuge; Toshiharu Yamaguchi; Tetsuichiro Muto; Masatoshi Makuuchi
Journal:  World J Surg       Date:  2004-01-08       Impact factor: 3.352

9.  Randomized, clinical trial of Ligasure vs conventional diathermy in hemorrhoidectomy.

Authors:  Ernest J Franklin; Seema Seetharam; Jennifer Lowney; Paul G Horgan
Journal:  Dis Colon Rectum       Date:  2003-10       Impact factor: 4.585

10.  Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases.

Authors:  David A Kooby; Jennifer Stockman; Leah Ben-Porat; Mithat Gonen; William R Jarnagin; Ronald P Dematteo; Scott Tuorto; David Wuest; Leslie H Blumgart; Yuman Fong
Journal:  Ann Surg       Date:  2003-06       Impact factor: 12.969

View more
  4 in total

Review 1.  Non-vascular experimental and clinical applications of advanced bipolar radiofrequency thermofusion technology in the thorax and abdomen: a systematic review.

Authors:  Shobhit Arya; Hugh Mackenzie; George B Hanna
Journal:  Surg Endosc       Date:  2014-11-19       Impact factor: 4.584

2.  Axillary lymph node dissection for breast cancer utilizing Harmonic Focus®.

Authors:  Katherine T Ostapoff; David Euhus; Xian-Jin Xie; Madhu Rao; Amy Moldrem; Roshni Rao
Journal:  World J Surg Oncol       Date:  2011-08-15       Impact factor: 2.754

3.  LigaSure Impact™ versus conventional dissection technique in pylorus-preserving pancreatoduodenectomy in clinical suspicion of cancerous tumours on the head of the pancreas: study protocol for a randomised controlled trial.

Authors:  Tobias Gehrig; Phillip Knebel; Verena Scheel; Ulf Hinz; Christoph M Seiler; Beat P Müller-Stich; Markus W Büchler; Carsten N Gutt
Journal:  Trials       Date:  2011-06-29       Impact factor: 2.279

4.  SEALIVE: the use of technical vessel-sealing devices for recipient hepatectomy in liver transplantation: study protocol for a randomized controlled trial.

Authors:  Philipp Houben; Elias Khajeh; Ulf Hinz; Phillip Knebel; Markus K Diener; Arianeb Mehrabi
Journal:  Trials       Date:  2018-07-16       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.